Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.25 MB | Adobe PDF |
Advisor(s)
Abstract(s)
A successful gene therapy approach can prevent or treat congenital and acquired diseases. However, there is still no ideal non-viral vector for gene delivery in a safe and timely manner. In this report the anionic polymer hyaluronic acid (HA) was investigated as a potential vector for gene therapy. Due to its intrinsic characteristics it constitutes an excellent candidate to deliver therapeutic genes, pending the modification of its surface charge.
Description
Keywords
Gene therapy Hyaluronic acid Polymer modification Retina Biocompatibility
Citation
Mater. Sci. Eng. C, 58, 2016, 264–272
Publisher
Elsevier